Retinal Pigment Epithelial Cell Line with Fast Differentiation and Improved Barrier Properties
Retinal pigment epithelium (RPE) acts as an outer blood−retinal barrier that limits the access of circulating xenobiotics to the eye. In addition, the RPE limits posterior elimination of intravitreally injected drugs to circulation. Thus, permeation in the RPE has a significant effect on o...
Main Authors: | Laura Hellinen, Lea Pirskanen, Unni Tengvall-Unadike, Arto Urtti, Mika Reinisalo |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-08-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/11/8/412 |
Similar Items
-
Drug Flux Across RPE Cell Models: The Hunt for An Appropriate Outer Blood–Retinal Barrier Model for Use in Early Drug Discovery
by: Laura Hellinen, et al.
Published: (2020-02-01) -
Research progress of tight junction between retinal pigment epithelium cells and its disruption in the pathogenesis of age-related macular degeneration
by: Qiao-Yun Wang, et al.
Published: (2023-02-01) -
Retraction: Hellinen et al. Retinal Pigment Epithelial Cell Line with Fast Differentiation and Improved Barrier Properties. <i>Pharmaceutics</i> 2019, <i>11</i>, 412
by: Laura Hellinen, et al.
Published: (2022-03-01) -
Polarity and epithelial-mesenchymal transition of retinal pigment epithelial cells in proliferative vitreoretinopathy
by: Hui Zou, et al.
Published: (2020-10-01) -
Foveal simple hamartoma of retinal pigment epithelium
by: Prabu Baskaran, et al.
Published: (2018-01-01)